மனம் விஷயங்கள் மனநல மருத்துவம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மனம் விஷயங்கள் மனநல மருத்துவம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மனம் விஷயங்கள் மனநல மருத்துவம் Today - Breaking & Trending Today

Investegate |Nexstim Oyj Announcements | Nexstim Oyj: Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD


Nexstim Oyj
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD
Press release, Helsinki, 16.04.2021, 12.00 pm (EEST)
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT® Systems to Treat MDD
Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( Nexstim or Company ) announces that the company’s SmartFocus® nTMS technology used at Mind Matters Psychiatry MD, US has generated positive feedback from its use in treating patients with depression. ....

Eteläuomen Läi , United States , Flower Mound , Oladele Adebogun , Mikko Karvinen , Nexstim Plc , Nexstim Or Company , Nexstim Receives Positive Feedback , Mind Matters Psychiatry , Their Two , Receives Positive Feedback , Navigated Brain Therapy , Navigated Brain Stimulation , Nasdaq First North Growth Market Finland , Nasdaq First North Growth Market , ஒன்றுபட்டது மாநிலங்களில் , பூ மேடு , மனம் விஷயங்கள் மனநல மருத்துவம் , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை பின்லாந்து , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை ,

Nexstim Oyj: Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT Systems to Treat MDD


(0)
Press release, Helsinki, 16.04.2021, 12.00 pm (EEST)
Nexstim Receives Positive Feedback from Mind Matters Psychiatry MD on Use of Their Two NBT Systems to Treat MDD
Nexstim Plc (NXTMH:HEX, NXTMS:STO) ( Nexstim or Company ) announces that the company s SmartFocus nTMS technology used at Mind Matters Psychiatry MD, US has generated positive feedback from its use in treating patients with depression.
Oladele Adebogun M.D. said,
I was initially introduced to Nexstim by the early outcomes of their registry which showed 50% remission rates in a small number of patients suffering from major depressive disorder. I purchased my first system and have been so impressed with my own patient outcomes that I have added this second system for my patients located in Flower Mound, Texas. I have even been able to successfully treat those patients who failed to respond to TMS on our prior non-Nexstim system. I am proud to contribute to the latest Nexstim treatment outcomes ....

Eteläuomen Läi , United States , Flower Mound , Oladele Adebogun , Mikko Karvinen , Nexstim Plc , Nexstim Or Company , Receives Positive Feedback , Mind Matters Psychiatry , Their Two , Matters Psychiatry , Navigated Brain Therapy , Navigated Brain Stimulation , Nasdaq First North Growth Market Finland , Nasdaq First North Growth Market , ஒன்றுபட்டது மாநிலங்களில் , பூ மேடு , மனம் விஷயங்கள் மனநல மருத்துவம் , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை பின்லாந்து , நாஸ்டாக் முதல் வடக்கு வளர்ச்சி சந்தை ,